GLPG
Price
$28.83
Change
+$0.28 (+0.98%)
Updated
Jul 3 closing price
Capitalization
1.9B
17 days until earnings call
GNFT
Price
$3.87
Change
-$0.02 (-0.51%)
Updated
Jul 3 closing price
Capitalization
196.8M
78 days until earnings call
Interact to see
Advertisement

GLPG vs GNFT

Header iconGLPG vs GNFT Comparison
Open Charts GLPG vs GNFTBanner chart's image
Galapagos
Price$28.83
Change+$0.28 (+0.98%)
Volume$147.6K
Capitalization1.9B
Genfit SA
Price$3.87
Change-$0.02 (-0.51%)
Volume$330
Capitalization196.8M
GLPG vs GNFT Comparison Chart in %
Loading...
GLPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNFT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLPG vs. GNFT commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLPG is a Hold and GNFT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (GLPG: $28.83 vs. GNFT: $3.87)
Brand notoriety: GLPG and GNFT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLPG: 43% vs. GNFT: 5%
Market capitalization -- GLPG: $1.9B vs. GNFT: $195.88M
GLPG [@Biotechnology] is valued at $1.9B. GNFT’s [@Biotechnology] market capitalization is $195.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLPG’s FA Score shows that 0 FA rating(s) are green whileGNFT’s FA Score has 1 green FA rating(s).

  • GLPG’s FA Score: 0 green, 5 red.
  • GNFT’s FA Score: 1 green, 4 red.
According to our system of comparison, both GLPG and GNFT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLPG’s TA Score shows that 6 TA indicator(s) are bullish while GNFT’s TA Score has 5 bullish TA indicator(s).

  • GLPG’s TA Score: 6 bullish, 3 bearish.
  • GNFT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, GLPG is a better buy in the short-term than GNFT.

Price Growth

GLPG (@Biotechnology) experienced а +4.04% price change this week, while GNFT (@Biotechnology) price change was +0.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

GLPG is expected to report earnings on Jul 23, 2025.

GNFT is expected to report earnings on Sep 22, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLPG($1.9B) has a higher market cap than GNFT($197M). GNFT has higher P/E ratio than GLPG: GNFT (109.28) vs GLPG (54.80). GLPG YTD gains are higher at: 4.836 vs. GNFT (4.172).
GLPGGNFTGLPG / GNFT
Capitalization1.9B197M963%
EBITDA-127.75MN/A-
Gain YTD4.8364.172116%
P/E Ratio54.80109.2850%
Revenue288MN/A-
Total Cash3.3BN/A-
Total Debt10.9MN/A-
FUNDAMENTALS RATINGS
GLPG vs GNFT: Fundamental Ratings
GLPG
GNFT
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
83
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9197
PRICE GROWTH RATING
1..100
5061
P/E GROWTH RATING
1..100
642
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GLPG's Valuation (74) in the Biotechnology industry is in the same range as GNFT (83). This means that GLPG’s stock grew similarly to GNFT’s over the last 12 months.

GLPG's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as GNFT (100). This means that GLPG’s stock grew similarly to GNFT’s over the last 12 months.

GLPG's SMR Rating (91) in the Biotechnology industry is in the same range as GNFT (97). This means that GLPG’s stock grew similarly to GNFT’s over the last 12 months.

GLPG's Price Growth Rating (50) in the Biotechnology industry is in the same range as GNFT (61). This means that GLPG’s stock grew similarly to GNFT’s over the last 12 months.

GNFT's P/E Growth Rating (2) in the Biotechnology industry is somewhat better than the same rating for GLPG (64). This means that GNFT’s stock grew somewhat faster than GLPG’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GLPGGNFT
RSI
ODDS (%)
Bearish Trend 5 days ago
65%
Bullish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
74%
Bullish Trend 4 days ago
64%
Momentum
ODDS (%)
Bullish Trend 4 days ago
65%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
Bullish Trend 4 days ago
67%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
57%
Bullish Trend 4 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
59%
Bullish Trend 5 days ago
71%
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 4 days ago
73%
Aroon
ODDS (%)
Bearish Trend 4 days ago
72%
Bullish Trend 4 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
GLPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNFT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VRLCX19.490.24
+1.25%
Voya Large Cap Growth Port R6
FSUVX22.930.17
+0.75%
Fidelity SAI US LowVolatility Idx
SMCIX21.380.13
+0.61%
Shelton S&P Smallcap Index Investor
FTUCX61.160.30
+0.49%
Fidelity Advisor Telecommunications C
IMLPX10.23-0.01
-0.10%
MainGate MLP I

GLPG and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLPG has been loosely correlated with RGNX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if GLPG jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLPG
1D Price
Change %
GLPG100%
+0.98%
RGNX - GLPG
37%
Loosely correlated
+1.39%
BEAM - GLPG
36%
Loosely correlated
+0.65%
CRSP - GLPG
34%
Loosely correlated
+0.97%
NTLA - GLPG
34%
Loosely correlated
+0.09%
RPRX - GLPG
34%
Loosely correlated
+0.50%
More

GNFT and

Correlation & Price change

A.I.dvisor tells us that GNFT and BCDA have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNFT and BCDA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNFT
1D Price
Change %
GNFT100%
-0.51%
BCDA - GNFT
26%
Poorly correlated
+1.73%
QURE - GNFT
24%
Poorly correlated
+0.98%
FENC - GNFT
24%
Poorly correlated
+3.04%
GLPG - GNFT
23%
Poorly correlated
+0.98%
GUTS - GNFT
23%
Poorly correlated
+0.61%
More